https://ally-bridge.com/news/ally-bridge-group-announces-key-promotions-and-new-appointment/2026-08-12T15:37:07+08:00https://ally-bridge.com/news/private-equity-portfolio-news-aadi-bioscience-transforms-with-in-licensing-of-novel-adc-portfolio-100-million-sale-of-fyarro-and-100-million-pipe-financing/2026-08-21T11:08:31+08:00https://ally-bridge.com/news/biotech-ipos-slow-after-record-breaking-2021/2026-09-17T11:48:10+08:00https://ally-bridge.com/news/private-equity-portfolio-news-aerin-medical-secures-60-million-in-equity-financing/2026-08-12T10:04:31+08:00https://ally-bridge.com/news/solomon-r-guggenheim-foundation-elects-frank-yu-to-the-board-of-trustees/2026-08-12T10:13:46+08:00https://ally-bridge.com/news/altheadx-completes-30m-series-c-financing/2026-08-12T13:55:57+08:00https://ally-bridge.com/news/late-stage-investors-seek-to-bring-medtech-startups-to-the-home-stretch/2026-09-17T11:47:53+08:00https://ally-bridge.com/news/alumis-announces-upsized-259m-series-c-financing-to-advance-clinical-stage-pipeline-of-oral-therapies-designed-to-address-immune-dysfunction/2026-08-11T17:29:04+08:00https://ally-bridge.com/news/promis-neurosciences-strengthens-board-with-appointment-of-slanix-paul-alex-pharm-d-president-and-portfolio-manager-public-equity-of-ally-bridge-group/2026-08-11T16:05:45+08:00https://ally-bridge.com/news/alzheon-announces-10-million-series-a-financing/2026-08-12T14:05:39+08:00https://ally-bridge.com/news/private-equity-portfolio-news-arbor-biotechnologies-closes-215-million-oversubscribed-series-b-financing-to-advance-next-generation-precision-editing-therapeutics/2026-08-12T10:33:07+08:00https://ally-bridge.com/news/arbor-biotechnologies-announces-73-9-million-series-c-financing-to-advance-novel-gene-editing-therapeutics/2026-08-11T16:34:55+08:00https://ally-bridge.com/news/public-equity-portfolio-news-atea-pharmaceuticals-announces-ind-clearance-of-at-527-for-covid-19-and-215-million-financing/2026-08-12T11:35:04+08:00https://ally-bridge.com/news/atea-pharmaceuticals-announces-closing-of-initial-public-offering/2026-08-12T11:30:15+08:00https://ally-bridge.com/news/private-equity-portfolio-news-cardiac-dimensions-raises-53-million-series-e-financing/2026-08-11T16:33:15+08:00https://ally-bridge.com/news/cargo-therapeutics-announces-110-0-million-private-placement-equity-financing/2026-08-11T17:01:46+08:00https://ally-bridge.com/news/private-equity-portfolio-news-ceribell-closes-50-million-equity-financing-round-led-by-ally-bridge-group/2026-08-11T18:11:12+08:00https://ally-bridge.com/news/promis-neurosciences-announces-up-to-175-million-private-placement-financing/2026-08-11T16:00:36+08:00https://ally-bridge.com/news/13-57-million-in-a-series-a-round-of-financing-to-accelerate-its-ongoing-phase-ii-iii-clinical-trial-for-bladder-cancer/2026-08-20T17:57:24+08:00https://ally-bridge.com/news/biobeat-technologies-ltd/2026-08-20T10:23:23+08:00https://ally-bridge.com/news/series-b-investment-for-pivotal-and-combo-immunotherapy-trials/2026-08-20T17:57:45+08:00https://ally-bridge.com/news/cg-oncology-raises-120-million-in-oversubscribed-series-e-financing-to-advance-clinical-stage-urologic-oncology-pipeline/2026-08-20T17:58:04+08:00https://ally-bridge.com/news/perspective-therapeutics-announces-pricing-of-175-million-underwritten-offering-of-common-stock-and-pre-funded-warrants/2026-08-11T15:55:41+08:00https://ally-bridge.com/news/cg-oncology-announces-105-million-oversubscribed-crossover-financing-to-support-continued-advancement-of-clinical-stage-bladder-cancer-pipeline/2026-08-11T18:06:02+08:00https://ally-bridge.com/news/private-equity-portfolio-news-cmr-surgical-raises-600-million-in-series-d-financing-led-by-softbank-vision-fund-2-and-co-led-by-ally-bridge-group/2026-08-20T10:25:42+08:00https://ally-bridge.com/news/solve-therapeutics-raises-120-million-to-develop-best-in-class-adcs-for-solid-tumors/2026-08-11T17:21:49+08:00https://ally-bridge.com/news/private-equity-portfolio-news-wuxi-pharmatech-announces-receipt-of-proposal/2026-08-12T14:03:06+08:00https://ally-bridge.com/news/private-equity-portfolio-news-wuxi-pharmatech-enters-into-definitive-merger-agreement/2026-05-21T12:59:54+08:00https://ally-bridge.com/news/how-ally-bridge-group-expects-to-build-on-top-of-wuxi-arbitrage-play/2026-08-12T15:57:33+08:00https://ally-bridge.com/news/private-equity-portfolio-news-wuxi-biologics-wuxi-apptechs-ipo-could-benefit-from-scarcity-value-ally-bridge-founder-frank-yu/2026-08-12T12:05:17+08:00https://ally-bridge.com/news/private-equity-portfolio-news-vitalconnect-inc-secures-100-million-in-financing/2026-08-11T16:39:22+08:00https://ally-bridge.com/news/private-equity-portfolio-news-pe-backed-wuxi-biologics-completes-hong-kong-re-listing/2026-05-21T13:01:07+08:00https://ally-bridge.com/news/hong-kongs-ally-bridge-invests-in-two-european-biopharmas/2026-05-21T12:29:20+08:00https://ally-bridge.com/news/private-equity-portfolio-news-wuxi-apptec-prices-a-share-ipo/2026-05-21T12:58:25+08:00https://ally-bridge.com/news/private-equity-portfolio-news-wuxi-apptec-said-to-file-for-1-billion-hong-kong-offering/2026-08-12T11:54:47+08:00https://ally-bridge.com/news/private-equity-portfolio-news-wuxi-apptec-successfully-prices-hong-kong-offering-in-stormy-market/2026-07-07T02:54:26+08:00https://ally-bridge.com/news/private-equity-portfolio-news-ally-bridge-group-leads-vida-healths-25-million-financing-to-scale-network-and-meet-increased-demand-for-virtual-care/2026-08-12T11:37:38+08:00https://ally-bridge.com/news/private-equity-portfolio-news-vida-health-raises-110-million-in-series-d-round-led-by-atlantic-centene-and-axa-venture-partners/2026-08-12T11:16:33+08:00https://ally-bridge.com/news/private-equity-portfolio-news-endeavor-biomedicines-closes-101m-series-b-financing-to-advance-clinical-stage-precision-medicine-pipeline/2026-08-20T11:31:01+08:00https://ally-bridge.com/news/private-equity-portfolio-news-endeavor-biomedicines-raises-132-5-million-oversubscribed-series-c-financing-to-advance-pipeline-of-transformational-medicines/2026-08-20T11:31:18+08:00https://ally-bridge.com/news/private-equity-portfolio-news-cmr-surgical-surpasses-15000-surgical-procedures-on-versius-globally-as-it-raises-165-million-to-support-continued-growth/2026-08-21T11:15:31+08:00https://ally-bridge.com/news/vida-health-announces-28-5-million-in-funding-appoints-joe-murad-ceo/2026-08-11T17:47:59+08:00https://ally-bridge.com/news/vida-health-appoints-leading-industry-executives-to-accelerate-growth-in-cardiometabolic-care-press-release/2026-08-11T16:14:53+08:00https://ally-bridge.com/news/endochoice-announces-57-million-raised-in-equity-financing/2026-08-21T11:07:57+08:00https://ally-bridge.com/news/private-equity-portfolio-news-ally-bridge-group-leads-vencloses-27-million-series-c-funding/2026-08-12T11:41:03+08:00https://ally-bridge.com/news/conventus-orthopaetics-raises-24-million-to-fuel-growth-and-innovation/2026-08-12T14:14:19+08:00https://ally-bridge.com/news/private-equity-portfolio-news-epicrispr-biotechnologies-secures-68-million-series-b-to-initiate-clinical-trial-for-first-in-class-disease-modifying-epigenetic-neuromuscular-therapy-for-fshd/2026-08-11T16:31:29+08:00https://ally-bridge.com/news/private-equity-portfolio-news-transcarent-raises-200-million-in-series-funding-highlighting-growing-demand-for-a-different-health-and-care-experience-aligned-with-the-needs-of-self-insured-employers/2026-08-12T10:26:42+08:00https://ally-bridge.com/news/transcarent-raises-126-million-series-d/2026-08-11T17:10:35+08:00https://ally-bridge.com/news/galvanize-therapeutics-raises-100-million-in-oversubscribed-series-c-financing-to-transform-the-treatment-of-cancer-and-chronic-lung-disease/2026-09-02T11:19:57+08:00https://ally-bridge.com/news/private-equity-portfolio-news-grail-announces-300-million-raised-in-oversubscribed-series-c-financing/2026-08-20T14:11:42+08:00https://ally-bridge.com/news/private-equity-portfolio-news-morgan-stanley-expansion-capital-and-ally-bridge-group-lead-135-million-investment-in-elligo/2026-08-12T10:45:20+08:00https://ally-bridge.com/news/private-equity-portfolio-news-hua-medicine-raises-117-4-million-in-series-d-series-e-financing/2026-08-12T12:02:32+08:00https://ally-bridge.com/news/immungene-raises-9-million-in-series-a-financing/2026-08-12T14:19:56+08:00https://ally-bridge.com/news/private-equity-portfolio-news-ally-bridge-group-co-leads-imperative-cares-85-million-series-c-financing/2026-08-20T16:59:09+08:00https://ally-bridge.com/news/kandu-inc-announces-30-million-financing-to-advance-stroke-recovery-and-rehabilitation/2026-08-20T16:09:24+08:00https://ally-bridge.com/news/private-equity-portfolio-news-imperative-care-raises-260-million-to-advance-innovations-that-elevate-stroke-care/2026-08-20T16:59:27+08:00https://ally-bridge.com/news/private-equity-portfolio-news-imperative-care-completes-initial-closing-of-series-e-financing-for-up-to-150-million-shacey-petrovic-appointed-to-vice-chair-board-of-directors/2026-08-20T16:59:42+08:00https://ally-bridge.com/news/private-equity-portfolio-news-kestra-medical-technologies-announces-196-million-oversubscribed-financing-round/2026-08-11T16:55:28+08:00https://ally-bridge.com/news/private-equity-portfolio-news-insightec-announces-150m-financing-to-fund-continued-growth/2026-08-20T14:23:23+08:00https://ally-bridge.com/news/private-equity-portfolio-news-lightforce-orthodontics-secures-80-million-series-d-funding-led-by-ally-bridge-group/2026-08-11T17:58:02+08:00https://ally-bridge.com/news/private-equity-portfolio-news-ally-bridge-group-leads-30-million-investment-in-israels-mavrik-dental/2026-05-21T10:42:38+08:00https://ally-bridge.com/news/private-equity-and-public-equity-portfolio-news-medavail-completes-84-million-private-placement-led-by-ally-bridge-group/2026-08-24T09:33:20+08:00https://ally-bridge.com/news/private-equity-portfolio-news-chinese-sovereign-wealth-fund-backs-linkdocs-151-million-series-d/2026-08-20T17:46:49+08:00https://ally-bridge.com/news/private-equity-portfolio-news-ally-bridge-group-keeps-cash-flowing-in-155-million-private-placement-in-tesaro/2026-05-21T12:13:05+08:00https://ally-bridge.com/news/ally-bridge-group-congratulates-medtech-sa-on-its-acquisition-by-zimmer-biomet/2026-08-12T12:13:00+08:00https://ally-bridge.com/news/private-equity-portfolio-news-tesaro-reaches-agreement-to-be-acquired-by-gsk/2026-08-12T11:53:44+08:00https://ally-bridge.com/news/ally-bridge-group-abg-expands-personalized-medicine-portfolio-invests-in-linkdoc-technology-limited-chinas-oncology-big-data-company/2026-08-20T17:47:09+08:00https://ally-bridge.com/news/mission-bio-secures-equity-financing-to-accelerate-single-cell-tri-omics-platform-expansion/2026-08-18T10:11:51+08:00https://ally-bridge.com/news/symic-biomedical-secures-15-million-in-series-a-financing/2026-08-13T10:52:20+08:00https://ally-bridge.com/news/otonomy-raises-49-million-in-oversubscribed-financing/2026-08-12T14:18:04+08:00https://ally-bridge.com/news/private-equity-portfolio-news-syapse-announces-68-million-strategic-investment-with-ally-bridge-group-and-northpond-ventures-to-expand-delivery-of-real-world-evidence-through-syapses-learni/2026-08-20T16:45:06+08:00https://ally-bridge.com/news/shandong-luoxin-pharmaceutical-receives-a-voluntary-conditional-offer/2026-08-12T18:04:14+08:00https://ally-bridge.com/news/sorrento-closes-150-million-private-placement-investments/2026-08-20T16:44:15+08:00https://ally-bridge.com/news/private-equity-portfolio-news-ally-bridge-group-co-leads-mainstay-medicals-108-million-equity-financing/2026-08-12T11:24:23+08:00https://ally-bridge.com/news/private-equity-portfolio-news-profoundbio-raises-112-million-in-oversubscribed-series-b-equity-financing-to-advance-its-clinical-stage-antibody-drug-conjugate-adc-pipeline/2026-08-20T15:19:41+08:00https://ally-bridge.com/news/private-equity-portfolio-news-sonoma-biotherapeutics-raises-265-million-in-an-oversubscribed-series-b-financing-to-translate-the-promise-of-cell-therapy-into-curative-medicines-for-autoimmune-and-ot/2026-08-12T11:05:50+08:00https://ally-bridge.com/news/private-equity-portfolio-news-pulmonx-closes-65-million-financing-and-adds-chief-financial-officer/2026-08-12T11:50:32+08:00https://ally-bridge.com/news/mainstay-medical-announces-us125-million-equity-financing-transaction/2026-08-11T17:40:44+08:00https://ally-bridge.com/news/private-equity-portfolio-news-shoreline-biosciences-announces-140-million-financing-to-advance-pipeline-of-next-generation-cell-immunotherapies/2026-08-12T10:34:10+08:00https://ally-bridge.com/news/private-equity-portfolio-news-ally-bridge-group-leads-pulmonxs-66-million-financing-to-support-commercial-acceleration-of-the-zephyr-valve-system/2026-08-12T11:36:36+08:00https://ally-bridge.com/news/shockwave-medical-gains-40-million-in-funding-for-lithoplasty-system/2026-07-02T18:45:36+08:00https://ally-bridge.com/news/private-equity-portfolio-news-ally-bridge-expands-early-stage-cancer-solutions-with-investment-in-quantum-surgical/2026-08-20T11:56:23+08:00https://ally-bridge.com/news/setpoint-medical-raises-140-million-in-private-financing-and-expands-leadership-team-to-support-commercialization-of-rheumatoid-arthritis-therapy/2026-08-11T16:11:43+08:00https://ally-bridge.com/news/3-v-biosciences-announces-closing-of-28-5m-financing-round/2026-08-12T14:12:00+08:00https://ally-bridge.com/news/private-equity-portfolio-news-quantum-surgical-secures-e40-million-to-support-the-commercial-launch-of-epione/2026-08-20T11:56:48+08:00https://ally-bridge.com/news/private-equity-and-public-equity-portfolio-news-rapidmicro-biosystems-raises-81-million-to-continue-global-expansion-of-automated-pharmaceutical-qc-platform-to-improve-data-integrity-and-safety-in-b/2026-08-20T10:47:21+08:00https://ally-bridge.com/news/rayzebio-propels-forward-with-418-million-raised-since-inception-to-advance-targeted-radiopharmaceuticals-for-cancer/2026-08-19T17:54:35+08:00https://ally-bridge.com/news/private-equity-portfolio-news-reflexion-adds-ally-bridge-group-to-investor-syndicate/2026-08-12T11:21:41+08:00https://ally-bridge.com/news/relievant-medsystems-raises-50-million-to-advance-the-treatment-for-chronic-vertebrogenic-low-back-pain/2026-08-11T18:08:14+08:00https://ally-bridge.com/news/calyxo-secures-40-million-series-f-financing-as-cvac-system-surpasses-40000-patients-treated-for-kidney-stone-removal/2026-08-11T17:15:10+08:00https://ally-bridge.com/news/imperative-care-announces-100-million-financing/2026-08-20T17:00:04+08:00https://ally-bridge.com/news/adaptimmune-announces-closing-of-initial-public-offering/2026-08-12T14:33:40+08:00https://ally-bridge.com/news/castle-biosciences-completes-acquisition-of-altheadx/2026-08-12T10:07:32+08:00https://ally-bridge.com/news/cargo-therapeutics-announces-pricing-of-initial-public-offering/2026-08-11T17:49:36+08:00https://ally-bridge.com/news/cargo-therapeutics-enters-into-agreement-to-be-acquired-by-concentra-biosciences-for-4-379-in-cash-per-share-plus-a-contingent-value-right/2026-08-11T16:16:21+08:00https://ally-bridge.com/news/ceribell-inc-announces-closing-of-upsized-initial-public-offering-and-full-exercise-of-the-underwriters-option-to-purchase-additional-shares/2026-08-11T17:31:41+08:00https://ally-bridge.com/news/cg-oncology-announces-closing-of-public-offering-and-full-exercise-of-underwriters-option-to-purchase-additional-shares/2026-08-11T16:46:53+08:00https://ally-bridge.com/news/illumina-acquires-grail-to-accelerate-patient-access-to-life-saving-multi-cancer-early-detection-test/2026-08-20T14:12:56+08:00https://ally-bridge.com/news/kestra-medical-technologies-ltd-announces-closing-of-upsized-initial-public-offering/2026-08-11T16:37:40+08:00https://ally-bridge.com/news/medavail-and-myos-rens-technology-announce-closing-of-business-combination/2026-08-12T11:29:16+08:00https://ally-bridge.com/news/wuxi-apptec-lists-h-shares-on-the-hong-kong-stock-exchange/2026-08-12T11:51:38+08:00https://ally-bridge.com/news/pulmonx-announces-closing-of-initial-public-offering-and-full-exercise-of-the-underwriters-option-to-purchase-additional-shares/2026-08-12T11:31:36+08:00https://ally-bridge.com/news/rapid-micro-biosystems-announces-exercise-and-closing-of-over-allotment-option-in-initial-public-offering/2026-08-20T10:48:45+08:00https://ally-bridge.com/news/bristol-myers-squibb-completes-acquisition-of-rayzebio-adding-differentiated-actinium-based-radiopharmaceutical-platform/2026-08-19T17:54:09+08:00https://ally-bridge.com/news/sagimet-biosciences-announces-closing-of-underwriters-option-to-purchase-additional-shares-of-series-a-common-stock-in-connection-with-its-upsized-initial-public-offering/2026-08-12T15:39:59+08:00https://ally-bridge.com/news/johnson-johnson-to-acquire-shockwave-medical/2026-08-11T17:27:21+08:00https://ally-bridge.com/news/bd-acquires-venclose-inc-to-extend-treatment-innovations-in-chronic-venous-disease/2026-08-12T15:45:29+08:00https://ally-bridge.com/news/finalization-of-vifor-pharma-acquisition/2026-08-12T10:05:10+08:00https://ally-bridge.com/news/boston-scientific-closes-nxthera-acquisition/2026-08-12T17:58:48+08:00https://ally-bridge.com/news/medtech-unplugged-series-the-cube-nyse-wired/2026-09-17T11:47:32+08:00https://ally-bridge.com/news/1312/2026-08-11T17:38:31+08:00https://ally-bridge.com/news/boston-scientific-closes-endochoice-acquisition/2026-08-21T10:59:28+08:00https://ally-bridge.com/news/hua-medicine-successfully-completes-initial-public-offering-and-listing-on-the-hong-kong-stock-exchange/2026-06-15T13:55:37+08:00https://ally-bridge.com/news/wuxi-apptec-announces-listing-of-initial-public-offering-of-common-stock-on-shanghai-stock-exchange/2026-08-12T14:31:29+08:00https://ally-bridge.com/news/wuxi-biologics-is-officially-listed-on-the-hong-kong-stock-exchange/2026-08-12T12:03:54+08:00https://ally-bridge.com/news/otonomy-prices-upsized-ipo-at-16-the-high-end-of-the-range/2026-08-12T14:15:44+08:00https://ally-bridge.com/news/genmab-completes-acquisition-of-profoundbio/2026-08-20T15:20:39+08:00https://ally-bridge.com/news/boston-scientific-announces-agreement-to-acquire-relievant-medsystems-inc/2026-08-11T17:54:38+08:00https://ally-bridge.com/news/sorrento-announces-closing-of-public-offering-of-common-stock/2026-08-20T16:44:32+08:00https://ally-bridge.com/news/news-advancell-closes-us-315-million-oversubscribed-series-d-financing-to-advance-targeted-alpha-therapies-and-expand-clinical-and-commercial-manufacturing-infrastructure/2026-09-02T11:13:11+08:00https://ally-bridge.com/news/irhythm-to-acquire-vitalconnect-expanding-its-cardiac-monitoring-platform-across-ambulatory-inpatient-and-hospital-to-home-care/2026-08-11T15:26:38+08:00